Qivitan 25 mg/ml Suspension for Injection for Cattle and Pigs

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

Compra'l ara

Descargar Fitxa tècnica (SPC)
07-03-2023

ingredients actius:

Cefquinome

Disponible des:

Livisto Int'l S.L.

Codi ATC:

QJ01DE90

Designació comuna internacional (DCI):

Cefquinome

formulario farmacéutico:

Suspension for injection

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cattle, Pigs

Área terapéutica:

Antimicrobial

Estat d'Autorització:

Authorized

Data d'autorització:

2017-02-02

Fitxa tècnica

                                Revised: February 2022
AN: 00454/2021 & 00456/2021
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Qivitan 25 mg/ml, suspension for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Cefquinome 25 mg
(equivalent to 29.64 mg cefquinome sulfate)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection
White to slightly yellowish suspension
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and pigs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of bacterial infections in cattle and pigs caused by
the Gram
positive and Gram negative microorganisms sensitive to cefquinome.
Cattle:
Respiratory disease caused by _Pasteurella multocida_ and _Mannheimia
haemolytica._
Digital dermatitis, infectious bulbar necrosis and acute interdigital
necrobacillosis (foul
in the foot).
Acute _E.coli_ mastitis with signs of systemic involvement.
Calves:
_E.coli_ septicaemia in calves
Pigs:
For the treatment of bacterial infections of the lungs and respiratory
tract caused by
_Pasteurella multocida, Haemophilus parasuis, Actinobacillus
pleuropneumoniae, _
_Streptococcus suis_ and other cefquinome-sensitive organisms.
Mastitis-Metritis-Agalactia
syndrome
(MMA)
with
involvement
of
_E.coli, _
_Staphylococcus _spp_., Streptococcus _spp. and other cefquinome
sensitive organisms.
Revised: February 2022
AN: 00454/2021 & 00456/2021
Page 2 of 7
Piglets:
Reduction of mortality in cases of meningitis caused by _Streptococcus
suis_.
For the treatment of:
Arthritis
caused
by
_Streptococcus _
spp._, _
_E. _
_coli_
and
other
cefquinome-sensitive
organisms.
Epidermitis (mild or moderate lesions) caused by _Staphylococcus
hyicus._
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to ß-lactam antibiotics, or
to any of the
excipients.
Do not administer to animals less than 1.25 kg body weight.
Do not use in poultry (including eggs) due to risk of spread of
antimicrob
                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte